Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 37 entries
Sorted by: Best Match Show Resources per page
Tyrosine kinase inhibitor induced isolated pericardial effusion.

Case reports in oncology

Agrawal V, Christenson ES, Showel MM.
PMID: 25848358
Case Rep Oncol. 2015 Feb 13;8(1):88-93. doi: 10.1159/000375484. eCollection 2015.

Long-term therapy with tyrosine kinase inhibitors (TKI) has resulted in improved outcomes for patients suffering from Bcr-Abl fusion protein-harboring leukemias. As a result, a growing population of patients on TKI therapy present to their primary care providers. In this...

Cite
Agrawal V, Christenson ES, Showel MM. Tyrosine kinase inhibitor induced isolated pericardial effusion. Case Rep Oncol. 2015;8(1):88-93doi: 10.1159/000375484.
Agrawal, V., Christenson, E. S., & Showel, M. M. (2015). Tyrosine kinase inhibitor induced isolated pericardial effusion. Case reports in oncology, 8(1), 88-93. https://doi.org/10.1159/000375484
Agrawal, Vineet, et al. "Tyrosine kinase inhibitor induced isolated pericardial effusion." Case reports in oncology vol. 8,1 (2015): 88-93. doi: https://doi.org/10.1159/000375484
Agrawal V, Christenson ES, Showel MM. Tyrosine kinase inhibitor induced isolated pericardial effusion. Case Rep Oncol. 2015 Feb 13;8(1):88-93. doi: 10.1159/000375484. eCollection 2015. PMID: 25848358; PMCID: PMC4361914.
Copy Download .nbib Format: NLM
Diary of a trip to China.

New Jersey nurse

Just G, Shore MM.
PMID: 6583656
N J Nurse. 1984 Jan-Feb;14(1):10-1.

No abstract available.

Cite
Just G, Shore MM. Diary of a trip to China. N J Nurse. 1984;14(1):10-1
Just, G., & Shore, M. M. (1984). Diary of a trip to China. New Jersey nurse, 14(1), 10-1.
Just, G, and Shore, M M. "Diary of a trip to China." New Jersey nurse vol. 14,1 (1984): 10-1.
Just G, Shore MM. Diary of a trip to China. N J Nurse. 1984 Jan-Feb;14(1):10-1. PMID: 6583656.
Copy Download .nbib Format: NLM
Analgesic, anti-inflammatory, and antipyretic effects of Ixora coccinea.

Journal of basic and clinical physiology and pharmacology

Ali Adnan MS, Al-Amin MM, Nasir Uddin MM, Shohel M, Bhattacharjee R, Hannan JM, Das BK.
PMID: 24468614
J Basic Clin Physiol Pharmacol. 2014 Jan 27; doi: 10.1515/jbcpp-2013-0125. Epub 2014 Jan 27.

Abstract Background: The present study was carried out to explore the potential of the ethanol extract of Ixora coccinea L. (IC) leaves as analgesic, anti-inflammatory and antipyretic agents using the hot-plate, acetic acid-induced writhing, carrageenan-induced paw edema and brewer's...

Cite
Ali Adnan MS, Al-Amin MM, Nasir Uddin MM, et al. Analgesic, anti-inflammatory, and antipyretic effects of Ixora coccinea. J Basic Clin Physiol Pharmacol. 2014;doi: 10.1515/jbcpp-2013-0125.
Ali Adnan, M. S., Al-Amin, M. M., Nasir Uddin, M. M., Shohel, M., Bhattacharjee, R., Hannan, J. M., & Das, B. K. (2014). Analgesic, anti-inflammatory, and antipyretic effects of Ixora coccinea. Journal of basic and clinical physiology and pharmacology, . https://doi.org/10.1515/jbcpp-2013-0125
Ali Adnan, Md Syed, et al. "Analgesic, anti-inflammatory, and antipyretic effects of Ixora coccinea." Journal of basic and clinical physiology and pharmacology vol. (2014). doi: https://doi.org/10.1515/jbcpp-2013-0125
Ali Adnan MS, Al-Amin MM, Nasir Uddin MM, Shohel M, Bhattacharjee R, Hannan JM, Das BK. Analgesic, anti-inflammatory, and antipyretic effects of Ixora coccinea. J Basic Clin Physiol Pharmacol. 2014 Jan 27; doi: 10.1515/jbcpp-2013-0125. Epub 2014 Jan 27. PMID: 24468614.
Copy Download .nbib Format: NLM
Integrated climate-chemical indicators of diffuse pollution from land to water.

Scientific reports

Mellander PE, Jordan P, Bechmann M, Fovet O, Shore MM, McDonald NT, Gascuel-Odoux C.
PMID: 29343796
Sci Rep. 2018 Jan 17;8(1):944. doi: 10.1038/s41598-018-19143-1.

Management of agricultural diffuse pollution to water remains a challenge and is influenced by the complex interactions of rainfall-runoff pathways, soil and nutrient management, agricultural landscape heterogeneity and biogeochemical cycling in receiving water bodies. Amplified cycles of weather can...

Cite
Mellander PE, Jordan P, Bechmann M, et al. Integrated climate-chemical indicators of diffuse pollution from land to water. Sci Rep. 2018;8(1):944doi: 10.1038/s41598-018-19143-1.
Mellander, P. E., Jordan, P., Bechmann, M., Fovet, O., Shore, M. M., McDonald, N. T., & Gascuel-Odoux, C. (2018). Integrated climate-chemical indicators of diffuse pollution from land to water. Scientific reports, 8(1), 944. https://doi.org/10.1038/s41598-018-19143-1
Mellander, Per-Erik, et al. "Integrated climate-chemical indicators of diffuse pollution from land to water." Scientific reports vol. 8,1 (2018): 944. doi: https://doi.org/10.1038/s41598-018-19143-1
Mellander PE, Jordan P, Bechmann M, Fovet O, Shore MM, McDonald NT, Gascuel-Odoux C. Integrated climate-chemical indicators of diffuse pollution from land to water. Sci Rep. 2018 Jan 17;8(1):944. doi: 10.1038/s41598-018-19143-1. PMID: 29343796; PMCID: PMC5772433.
Copy Download .nbib Format: NLM
Formation of Nanoscale [Ge.

Angewandte Chemie (International ed. in English)

Shohel M, Bjorklund JL, Smith JA, Kravchuk DV, Mason SE, Forbes TZ.
PMID: 33482020
Angew Chem Int Ed Engl. 2021 Apr 12;60(16):8755-8759. doi: 10.1002/anie.202017321. Epub 2021 Mar 09.

Keggin-type polyaluminum cations belong to a unique class of compounds with their large positive charge, hydroxo bridges, and divergent isomerization/oligomerization. Previous reports indicated that oligomerization of this species can only occur through one isomer (δ), but herein we report...

Cite
Shohel M, Bjorklund JL, Smith JA, et al. Formation of Nanoscale [Ge. Angew Chem Int Ed Engl. 2021;60(16):8755-8759doi: 10.1002/anie.202017321.
Shohel, M., Bjorklund, J. L., Smith, J. A., Kravchuk, D. V., Mason, S. E., & Forbes, T. Z. (2021). Formation of Nanoscale [Ge. Angewandte Chemie (International ed. in English), 60(16), 8755-8759. https://doi.org/10.1002/anie.202017321
Shohel, Mohammad, et al. "Formation of Nanoscale [Ge." Angewandte Chemie (International ed. in English) vol. 60,16 (2021): 8755-8759. doi: https://doi.org/10.1002/anie.202017321
Shohel M, Bjorklund JL, Smith JA, Kravchuk DV, Mason SE, Forbes TZ. Formation of Nanoscale [Ge. Angew Chem Int Ed Engl. 2021 Apr 12;60(16):8755-8759. doi: 10.1002/anie.202017321. Epub 2021 Mar 09. PMID: 33482020.
Copy Download .nbib Format: NLM
Density functional theory and thermodynamics analysis of MAl.

The Journal of chemical physics

Bjorklund JL, Shohel M, Bennett JW, Smith JA, Carolan ME, Hollar E, Forbes TZ, Mason SE.
PMID: 33588534
J Chem Phys. 2021 Feb 14;154(6):064303. doi: 10.1063/5.0038962.

Polyaluminum cations, such as the MAl

Cite
Bjorklund JL, Shohel M, Bennett JW, et al. Density functional theory and thermodynamics analysis of MAl. J Chem Phys. 2021;154(6):064303doi: 10.1063/5.0038962.
Bjorklund, J. L., Shohel, M., Bennett, J. W., Smith, J. A., Carolan, M. E., Hollar, E., Forbes, T. Z., & Mason, S. E. (2021). Density functional theory and thermodynamics analysis of MAl. The Journal of chemical physics, 154(6), 064303. https://doi.org/10.1063/5.0038962
Bjorklund, Jennifer L, et al. "Density functional theory and thermodynamics analysis of MAl." The Journal of chemical physics vol. 154,6 (2021): 064303. doi: https://doi.org/10.1063/5.0038962
Bjorklund JL, Shohel M, Bennett JW, Smith JA, Carolan ME, Hollar E, Forbes TZ, Mason SE. Density functional theory and thermodynamics analysis of MAl. J Chem Phys. 2021 Feb 14;154(6):064303. doi: 10.1063/5.0038962. PMID: 33588534.
Copy Download .nbib Format: NLM
Added burden of mental disorders on health status among patients with chronic obstructive pulmonary disease.

Primary care companion to the Journal of clinical psychiatry

Felker B, Bush KR, Harel O, Shofer JB, Shores MM, Au DH.
PMID: 21085558
Prim Care Companion J Clin Psychiatry. 2010;12(4). doi: 10.4088/PCC.09m00858gry.

OBJECTIVE: Patients with chronic obstructive pulmonary disease (COPD) and comorbid mental disorders are known to have worse health status. The association between these variables remains complex and poorly understood. We sought to better understand the association between COPD severity,...

Cite
Felker B, Bush KR, Harel O, et al. Added burden of mental disorders on health status among patients with chronic obstructive pulmonary disease. Prim Care Companion J Clin Psychiatry. 2010;12(4)doi: 10.4088/PCC.09m00858gry.
Felker, B., Bush, K. R., Harel, O., Shofer, J. B., Shores, M. M., & Au, D. H. (2010). Added burden of mental disorders on health status among patients with chronic obstructive pulmonary disease. Primary care companion to the Journal of clinical psychiatry, 12(4), . https://doi.org/10.4088/PCC.09m00858gry
Felker, Bradford, et al. "Added burden of mental disorders on health status among patients with chronic obstructive pulmonary disease." Primary care companion to the Journal of clinical psychiatry vol. 12,4 (2010). doi: https://doi.org/10.4088/PCC.09m00858gry
Felker B, Bush KR, Harel O, Shofer JB, Shores MM, Au DH. Added burden of mental disorders on health status among patients with chronic obstructive pulmonary disease. Prim Care Companion J Clin Psychiatry. 2010;12(4). doi: 10.4088/PCC.09m00858gry. PMID: 21085558; PMCID: PMC2983456.
Copy Download .nbib Format: NLM
Interaction of palmitic Acid with metoprolol succinate at the binding sites of bovine serum albumin.

Advanced pharmaceutical bulletin

Rahman M, Prianka F, Shohel M, Mazid MA.
PMID: 25436195
Adv Pharm Bull. 2014 Dec;4(4):379-83. doi: 10.5681/apb.2014.056. Epub 2014 Aug 10.

PURPOSE: The aim of this study was to characterize the binding profile as well as to notify the interaction of palmitic acid with metoprolol succinate at its binding site on albumin.METHODS: The binding of metoprolol succinate to bovine serum...

Cite
Rahman M, Prianka F, Shohel M, et al. Interaction of palmitic Acid with metoprolol succinate at the binding sites of bovine serum albumin. Adv Pharm Bull. 2014;4(4):379-83doi: 10.5681/apb.2014.056.
Rahman, M., Prianka, F., Shohel, M., & Mazid, M. A. (2014). Interaction of palmitic Acid with metoprolol succinate at the binding sites of bovine serum albumin. Advanced pharmaceutical bulletin, 4(4), 379-83. https://doi.org/10.5681/apb.2014.056
Rahman, Mashiur, et al. "Interaction of palmitic Acid with metoprolol succinate at the binding sites of bovine serum albumin." Advanced pharmaceutical bulletin vol. 4,4 (2014): 379-83. doi: https://doi.org/10.5681/apb.2014.056
Rahman M, Prianka F, Shohel M, Mazid MA. Interaction of palmitic Acid with metoprolol succinate at the binding sites of bovine serum albumin. Adv Pharm Bull. 2014 Dec;4(4):379-83. doi: 10.5681/apb.2014.056. Epub 2014 Aug 10. PMID: 25436195; PMCID: PMC4137429.
Copy Download .nbib Format: NLM
Caregiver perceptions of importance of COVID-19 preventative health guidelines and difficulty following guidelines are associated with child adherence rates.

Families, systems & health : the journal of collaborative family healthcare

Howe MM, Feldman ECH, Lampert SL, Kenney AE, Davies WH, Greenley RN.
PMID: 34735209
Fam Syst Health. 2021 Dec;39(4):632-637. doi: 10.1037/fsh0000641. Epub 2021 Nov 04.

OBJECTIVE: To describe child adherence to four preventative-health guidelines during the COVID-19 pandemic and investigate caregiver-level correlates of adherence.METHOD: Two hundred thirty-six caregivers (75% female) of children ages 6-12 years (RESULTS: Child adherence was highest for mask-wearing (median [Mdn]...

Cite
Howe MM, Feldman ECH, Lampert SL, et al. Caregiver perceptions of importance of COVID-19 preventative health guidelines and difficulty following guidelines are associated with child adherence rates. Fam Syst Health. 2021;39(4):632-637doi: 10.1037/fsh0000641.
Howe, M. M., Feldman, E. C. H., Lampert, S. L., Kenney, A. E., Davies, W. H., & Greenley, R. N. (2021). Caregiver perceptions of importance of COVID-19 preventative health guidelines and difficulty following guidelines are associated with child adherence rates. Families, systems & health : the journal of collaborative family healthcare, 39(4), 632-637. https://doi.org/10.1037/fsh0000641
Howe, Meghan M, et al. "Caregiver perceptions of importance of COVID-19 preventative health guidelines and difficulty following guidelines are associated with child adherence rates." Families, systems & health : the journal of collaborative family healthcare vol. 39,4 (2021): 632-637. doi: https://doi.org/10.1037/fsh0000641
Howe MM, Feldman ECH, Lampert SL, Kenney AE, Davies WH, Greenley RN. Caregiver perceptions of importance of COVID-19 preventative health guidelines and difficulty following guidelines are associated with child adherence rates. Fam Syst Health. 2021 Dec;39(4):632-637. doi: 10.1037/fsh0000641. Epub 2021 Nov 04. PMID: 34735209.
Copy Download .nbib Format: NLM
Advances in treating acute myeloid leukemia.

F1000prime reports

Showel MM, Levis M.
PMID: 25374674
F1000Prime Rep. 2014 Oct 01;6:96. doi: 10.12703/P6-96. eCollection 2014.

Acute myeloid leukemia (AML) arises within the bone marrow from a malignant hematopoietic progenitor cell. Though AML is still often fatal, cure rates overall continue to improve incrementally yet steadily, primarily for two reasons: first, insights into the pathogenesis...

Cite
Showel MM, Levis M. Advances in treating acute myeloid leukemia. F1000Prime Rep. 2014;6:96doi: 10.12703/P6-96.
Showel, M. M., & Levis, M. (2014). Advances in treating acute myeloid leukemia. F1000prime reports, 696. https://doi.org/10.12703/P6-96
Showel, Margaret M, and Levis, Mark. "Advances in treating acute myeloid leukemia." F1000prime reports vol. 6 (2014): 96. doi: https://doi.org/10.12703/P6-96
Showel MM, Levis M. Advances in treating acute myeloid leukemia. F1000Prime Rep. 2014 Oct 01;6:96. doi: 10.12703/P6-96. eCollection 2014. PMID: 25374674; PMCID: PMC4191225.
Copy Download .nbib Format: NLM
A phase II study of azacitidine in combination with granulocyte-macrophage colony-stimulating factor as maintenance treatment, after allogeneic blood or marrow transplantation in patients with poor-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).

Leukemia & lymphoma

Webster JA, Yogarajah M, Zahurak M, Symons H, Dezern AE, Gojo I, Prince GT, Morrow J, Jones RJ, Smith BD, Showel M.
PMID: 34284701
Leuk Lymphoma. 2021 Dec;62(13):3181-3191. doi: 10.1080/10428194.2021.1948029. Epub 2021 Jul 21.

Relapse is the most common cause of treatment failure following allogeneic blood or marrow transplantation (alloBMT) for AML or MDS. Post-transplant maintenance therapies may prevent relapse. We conducted a phase II trial combining azacitidine (AZA) with GM-CSF in non-relapsed,...

Cite
Webster JA, Yogarajah M, Zahurak M, et al. A phase II study of azacitidine in combination with granulocyte-macrophage colony-stimulating factor as maintenance treatment, after allogeneic blood or marrow transplantation in patients with poor-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Leuk Lymphoma. 2021;62(13):3181-3191doi: 10.1080/10428194.2021.1948029.
Webster, J. A., Yogarajah, M., Zahurak, M., Symons, H., Dezern, A. E., Gojo, I., Prince, G. T., Morrow, J., Jones, R. J., Smith, B. D., & Showel, M. (2021). A phase II study of azacitidine in combination with granulocyte-macrophage colony-stimulating factor as maintenance treatment, after allogeneic blood or marrow transplantation in patients with poor-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Leukemia & lymphoma, 62(13), 3181-3191. https://doi.org/10.1080/10428194.2021.1948029
Webster, Jonathan A, et al. "A phase II study of azacitidine in combination with granulocyte-macrophage colony-stimulating factor as maintenance treatment, after allogeneic blood or marrow transplantation in patients with poor-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)." Leukemia & lymphoma vol. 62,13 (2021): 3181-3191. doi: https://doi.org/10.1080/10428194.2021.1948029
Webster JA, Yogarajah M, Zahurak M, Symons H, Dezern AE, Gojo I, Prince GT, Morrow J, Jones RJ, Smith BD, Showel M. A phase II study of azacitidine in combination with granulocyte-macrophage colony-stimulating factor as maintenance treatment, after allogeneic blood or marrow transplantation in patients with poor-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Leuk Lymphoma. 2021 Dec;62(13):3181-3191. doi: 10.1080/10428194.2021.1948029. Epub 2021 Jul 21. PMID: 34284701.
Copy Download .nbib Format: NLM
A 2:1 randomized, open-label, phase II study of selinexor vs. physician's choice in older patients with relapsed or refractory acute myeloid leukemia.

Leukemia & lymphoma

Sweet K, Bhatnagar B, Döhner H, Donnellan W, Frankfurt O, Heuser M, Kota V, Liu H, Raffoux E, Roboz GJ, Röllig C, Showel MM, Strickland SA, Vives S, Tang S, Unger TJ, Joshi A, Shen Y, Alvarez MJ, Califano A, Crochiere M, Landesman Y, Kauffman M, Shah J, Shacham S, Savona MR, Montesinos P.
PMID: 34323164
Leuk Lymphoma. 2021 Dec;62(13):3192-3203. doi: 10.1080/10428194.2021.1950706. Epub 2021 Jul 29.

Selinexor, a selective inhibitor of nuclear export, has demonstrated promising activity in patients with acute myeloid leukemia (AML). This randomized, phase II study evaluated selinexor 60 mg twice weekly (

Cite
Sweet K, Bhatnagar B, Döhner H, et al. A 2:1 randomized, open-label, phase II study of selinexor vs. physician's choice in older patients with relapsed or refractory acute myeloid leukemia. Leuk Lymphoma. 2021;62(13):3192-3203doi: 10.1080/10428194.2021.1950706.
Sweet, K., Bhatnagar, B., Döhner, H., Donnellan, W., Frankfurt, O., Heuser, M., Kota, V., Liu, H., Raffoux, E., Roboz, G. J., Röllig, C., Showel, M. M., Strickland, S. A., Vives, S., Tang, S., Unger, T. J., Joshi, A., Shen, Y., Alvarez, M. J., Califano, A., Crochiere, M., Landesman, Y., Kauffman, M., Shah, J., Shacham, S., Savona, M. R., & Montesinos, P. (2021). A 2:1 randomized, open-label, phase II study of selinexor vs. physician's choice in older patients with relapsed or refractory acute myeloid leukemia. Leukemia & lymphoma, 62(13), 3192-3203. https://doi.org/10.1080/10428194.2021.1950706
Sweet, Kendra, et al. "A 2:1 randomized, open-label, phase II study of selinexor vs. physician's choice in older patients with relapsed or refractory acute myeloid leukemia." Leukemia & lymphoma vol. 62,13 (2021): 3192-3203. doi: https://doi.org/10.1080/10428194.2021.1950706
Sweet K, Bhatnagar B, Döhner H, Donnellan W, Frankfurt O, Heuser M, Kota V, Liu H, Raffoux E, Roboz GJ, Röllig C, Showel MM, Strickland SA, Vives S, Tang S, Unger TJ, Joshi A, Shen Y, Alvarez MJ, Califano A, Crochiere M, Landesman Y, Kauffman M, Shah J, Shacham S, Savona MR, Montesinos P. A 2:1 randomized, open-label, phase II study of selinexor vs. physician's choice in older patients with relapsed or refractory acute myeloid leukemia. Leuk Lymphoma. 2021 Dec;62(13):3192-3203. doi: 10.1080/10428194.2021.1950706. Epub 2021 Jul 29. PMID: 34323164.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 37 entries